The following is a summary of “Analysis of the Incidence and Outcomes of Breast Cancer in Women with Schizophrenia,” published in the November 2024 issue of Surgery by Den et al. Worldwide, breast ...

The state auditor report found poor record keeping and a lack of therapy to accompany psychotropic medications.

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Schizophrenia significantly shortens life expectancy by an estimated 15 years with excess mortality arising from multiple ...

Lyu X, Li Z, Chen S, et al. Transcranial direct current stimulation improves tardive dyskinesia in long-term hospitalized patients with chronic schizophrenia. Clin Neurophysiol. 2024;166:20-30. doi:10 ...

Antipsychotics are the best defense against relapse in schizophrenia, even though that protection often comes at the expense ...

Just six days from a momentous election, our writer – and most Americans – are feeling a mix of stress, anxiety and hope.

OBJECTIVE: This study aimed to associate antidepressants with versus without antipsychotics with readmission and suicide in patients with psychotic unipolar depression. METHODS: Swedish national ...

Antipsychotics, widely used to manage SSDs, are not considered or expected to be cognitive enhancers. Antipsychotics are primarily used to manage the core symptoms of SSDs, such as hallucinations ...

On the other hand, a toxicology report also found the liver and brain tested positive for drugs like antipsychotics to treat behavioral problems and drugs used to relieve allergies and cold.

All three ranked lowest among antipsychotics assessed for cognitive performance in SSDs when compared to placebo, the authors noted. "Based on the evidence considered, no clear recommendation can ...

Lower doses of antipsychotics have been associated with increased level of function but also with increased risk of relapse. This study presents findings from a specialized deprescribing clinic. In ...